Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q 2025Expect to ...
Market is experiencing significant growth due to the rising need for high-speed broadband connectivity, network ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback